# ABBOTT LABORATORIES: Form D filings

ABBOTT LABORATORIES, a pharmaceuticals company in Abbott Park, IL, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on March 15, 2011, reports $100,000 sold of a $100,000 offering to 1 investor.

Find out what ABBOTT LABORATORIES does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ABBOTT%20LABORATORIES%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ABBOTT%20LABORATORIES&page=%2Fdata%2Fform-d%2Fcompany%2Fabbott-laboratories-1800)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ABBOTT%20LABORATORIES%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ABBOTT%20LABORATORIES&page=%2Fdata%2Fform-d%2Fcompany%2Fabbott-laboratories-1800)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 100 Abbott Park Road, Abbott Park, IL, 60064
- Phone: (847) 937-6100
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Illinois
- Revenue range: Over $100,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1800

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 15, 2011 | New notice | $100,000 | $100,000 | $0 | 1 | Mar 1, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000110465911014429/0001104659-11-014429-index.htm) |
| Mar 12, 2010 | New notice | $70,000 | $70,000 | $0 | 1 | Mar 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000110465910014032/0001104659-10-014032-index.htm) |
| Mar 13, 2009 | New notice | $6,690,000 | $6,690,000 | $0 | 6 | Mar 2, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000110465909017676/0001104659-09-017676-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Carlos J. Alban | Executive Officer |  |
| William D. Smithburg | Director |  |
| Glenn F. Tilton | Director |  |
| Edward L. Michael | Executive Officer |  |
| Roxanne S. Austin | Director |  |
| Greg W. Linder | Executive Officer |  |
| Edward M. Liddy | Director |  |
| James V. Mazzo | Executive Officer |  |
| John M. Capek | Executive Officer |  |
| John C. Landgraf | Executive Officer |  |
| Mary T. Szela | Executive Officer |  |
| Miles D. White | Executive Officer, Director |  |
| Heather L. Mason | Executive Officer |  |
| William A. Osborn | Director |  |
| Richard A. Gonzalez | Executive Officer |  |
| Laura J. Schumacher | Executive Officer |  |
| Brian J. Blaser | Executive Officer |  |
| J. Scott White | Executive Officer |  |
| Robert J. Alpern | Director |  |
| Richard W. Ashley | Executive Officer |  |
| Stephen R. Fussell | Executive Officer |  |
| Thomas C. Freyman | Executive Officer |  |
| Phebe N. Novakovic | Director |  |
| Samuel C. Scott III | Director |  |
| A. David Forrest | Executive Officer |  |
| Robert B. Hance | Executive Officer |  |
| Roy S. Roberts | Director |  |
| David A.L. Owen | Director |  |
| H. Laurance Fuller | Director |  |
| Michael J. Warmuth | Executive Officer |  |
| W. James Farrell | Director |  |

[Every Form D from the week of Mar 14, 2011](https://specstream.ai/data/form-d/week/2011-03-14) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ABBOTT LABORATORIES reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).